基于代谢组学的肝气郁结证实验与临床研究
|
摘要
目的
肝气郁结证的发生非常普遍,是常见的中医内科证型,据中医内科临床住院病例的抽样统计中,大约有21%左右都有肝气郁结证侯的表现。近些年来,对于肝气郁结证本质生物学基础的研究较多,基本上都是单个系统的研究,主要是自主神经功能,分子生物学,微量元素,血液流变学,血浆生化,性激素,脏器损伤与量表测试等方面,至今还少有从多系统方面来研究肝气郁结证生物学基础的,对肝气郁结证目前仍未能够全面整体地阐明其生物学基础,代谢组学是现今生物与医学界的研究热点之一,它可以对各种常见生物体内几乎所有代谢产物进行定量分析,并描述生物体内代谢物动态变化,来发现代谢物变化与生理病理相关的改变关系,通过生物整体、系统或器官代谢途径及内源性代谢物质所受的不同影响因素,来研究机体的整体与全局。
应用代谢组学研究肝气郁结证候,正是中医整体观的具体科学表现。在本研究中,我们一方面利用情志刺激法制作大鼠肝气郁结证模型,并用柴胡疏肝散进行灌胃给药,观察造模及给药前后代谢组的差异变化,另一方面在临床上筛选肝气郁结证患者,通过尿液与血液中代谢物的变化,以期从小分子代谢物组学水平来整体、系统地探讨肝气郁结证的特征代谢表型与可能存在的生物学本质,为肝气郁结证的进一步防治提供相应的理论与实验依据。
方法
30只健康SD大鼠,体重220g,随机分为3组：正常组10只(A组)、模型组10只(B组)和给药组10只(C组),除正常组外,其余组采用夹尾法造模建立大鼠肝气郁结证模型,给药组造模后给予柴胡疏肝散灌胃(0.5g/ml),每天两次,各组分别在造模前一天、成模后、给药后收集尿液与血液,通过NMR波谱仪检测,运用代谢组学的方法,观察大鼠正常与肝气郁结模型以及柴胡疏肝散干预后,尿液与血液小分子代谢物组的差异性变化谱；并通过30例临床肝气郁结证患者与30例健康人的尿液与血液代谢组学观察,从整体性角度来探寻肝气郁结证的生物学基础和生理病理机制。
结果
一、动物实验研究
(1)与正常组相比,模型组肝气郁结证大鼠尿液马尿酸3.97ppm,7.55ppm,7.85ppmα-酮戊二酸3.01ppm,2.45 ppm柠檬酸(citrate)2.57 ppm,4.10 ppm,2.88 ppm异柠檬酸(isocitrate) 3.99 ppm,2.51ppm,2.43和乌头酸(aconitate) 3.77 ppm,6.96 ppm,3.96 ppm的谱峰相对积分面积明显降低,在尿液中含量降低,肌酸酐3.05 ppm,4.07ppm,丙酮2.23 ppm,乙酸1.93 ppm,肌酸3.93 ppm,3.03 ppm,烟酸(nicotinate) 4.41 ppm,1.41 ppm和5-羟基吲哚-3-乙酸(5-hydroxyindole-3-acetate,5-HIAA) 3.03 ppm,2.91 ppm,6.63 ppm,7.15 ppm谱峰相对积分面积显著增高,在尿液中的含量升高。
(2)肝气郁结证大鼠给予柴胡疏肝散干预后,给药组代谢表型为肌酸3.93,3.03,丙酮2.23肌酸酐3.05等含量明显下降,N-氧化三甲胺4.07, TMAO 3.27,牛磺酸3.43等含量明显增高。差异性表达代谢物结果显示,在造模后升高的差异表达代谢物在给予柴胡疏肝散干预后,大多数变化显著性降低或者已无显著性,其尿液代谢表型有向正常范围回归的趋势,呈现代谢网络修复的结果。这提示柴胡疏肝散对肝气郁结模型组大鼠有一定的恢复作用。
(3)从正常组和模型组肝气郁结证大鼠血液的比较代谢主成分分析来看,肝气郁结证大鼠血液代谢表型为不饱和脂肪酸HDL(0.83),谷氨酸G1u,谷氨酰胺G1n(2.43),撷氨酸Va1(1.03,0.98),VLDL(1.29,0.87),LDL,(1.25,0.85)类脂,(1.27)等化合物含量降低,乳酸Lac(1.31,1.32,4.11),N-乙酰糖蛋白Nac(2.02,2.05,2.06,2.09),胆碱,饱和脂肪酸,B-葡萄糖(3.47,3.91)含量上升。其代谢产物标志物可能是乳酸、胆碱、Nac、饱和脂肪酸、血糖、不饱和脂肪酸、HDL。
(4)给药组肝气郁结证大鼠给予柴胡疏肝散干预后,对血液1H-NMR谱峰积分值进行PCA分析后,得到得分图(scoreplot),两组均不能区分开,说明没有找到模型组与给药组的血液代谢表型差异化合物。
二、临床研究
(1)从正常组和肝气郁结证患者组尿液的比较代谢PCA分析来看,肝气郁结证患者尿液代谢表型为柠檬酸(citrate) 2.57,2.71,2.66,苯丙氨酸(phenylalanine) 3.12,色氨酸(tryptophan) 3.32,乙酰基柠檬酸(acetyl citric acid) 1.28,1.26,酪胺(tyramine) 2.71,2.53,乌头酸(aconitic acid) 3.17 3.45,3.77等化合物含量降低,肌酐(creatinine)3.06,4.06,4.1上升。
(2)对正常组与肝气郁结证患者组血液代谢组统计分析,两组血液的代谢组学PCA分析结果可以看出正常组与肝气郁结组之间PC没有区分开来,说明肝气郁结证患者血浆内源性代谢谱变化不明显。
结论
(1)肝气郁结证反应了能量代谢水平偏低,主要代谢途径是三羧酸循环,标志代谢物为柠檬酸和乌头酸的显著性降低。
(2)肝气郁结发生机制“怒伤肝”的生物学基础为烟酸的代谢。
(3)肝气郁结的抑郁症状与色氨酸代谢降低密切相关。
(4)柴胡疏肝散能够部分调控平抑肝气郁结证中发生异常的代谢产物。
(5)“肝主疏泄”对情志的调节作用通过酪氨酸代谢发挥作用。
(6)在肝气郁结证候中氨基酸代谢表现明显。
通过以上发现的肝气郁结证候代谢产物发生变化的生物基础,得到肝气郁结证生物体生理与病理发生的代谢组变化机制,对肝气郁结证的生物特征从代谢组学整体角度进行了成功的探索。
意义：初步发现肝气郁结证生物体的生理与病理发生变化的代谢机制基础是具有整体特征的多个代谢途径。
Objective:
The stagnation of Liver-Qi syndrome is a very far-ranging and pervasive syndrome, and also a familiar TCM (Traditional Chinese Medicine) internal medicine syndrome. According to sample statistic of TCM internal medicine history cases, around 21% patient get the stagnation of Liver-Qi syndrome. Recent years, entitative biological study to the stagnation of Liver-Qi syndrome is basically study of single system, which covers aspects of Blood Biochemical, autonomic nerve function, Trace Element Level, Blood rheology study, molecular biology, sex hormone, Damage of Organs, and Parametric Testing, etc., but few study is based on multi-system aspect. There is no illustrated biological foundation for the stagnation of Liver-Qi syndrome. Metabonomics is nowdays hot topic in biology and iatrology, which is used as quantitative analysis for almost all metabolites of all kinds of familiar organism, and describe the parameter dynamic change of metabolites, in order to find the relationship of metabolites change and pathophysiology, so that to study the macrocosm and the all, through studying different effect factor of the whole-body system, system and Apparatus etabolism approach and Endogenous etabolism matter. It is a representation of Tradicitional Chinese Medicine Holism, that apply metabonomics to The stagnation of Liver-Qi syndrome. In this study, on the one hand we use emotion stimulating and pinching the tail method to make rat model of stagnation of Liver-Qi syndrome, and intervent by Bupleurum smoothing liver medicine, observe the modification before and after take the medicin. On the other hand, the cilinic aspect, we choose patients with Ganqi stagnation, observe the change of emiction and blood metabolite, from the point of metabonomics, to holistic expound the biological fundation of stagnation of Liver-Qi syndrome, in order to analysis the Phenotype Characteristics and possible biological fundation of the stagnation of Liver-Qi sydrome, from a systemic and holistic Small molecule metabonomics level, and also provide relavant theory and experiment support for further prevention for the stagnation of Liver-Qi syndrome.
Method:
30 healthy SD rat, body weight 220g, divide to three groups by chance:Group A:Normal 10; Group B:model group 10; Group C: medicine group 10. Except for group A, the other two groups was made into model of the stagnation of Liver-Qi syndrome. Group C was provided Bupleurum smoothing liver medicine,0.5g/mL, twice per day. All groups is to collect emiction and blood samples the day before modelling, after modeling, and after take the medicine, go through NMR Spectrometer examination, and use metabonomics method, after observe group A, B and C, the change of emiction and blood Small-molecule metabolites, and meanwhile observe emiction and blood metabonomics study of 30 clinical patients with Ganqi stagnation and 30 healthy people, and study the biological fundation and pathophysiology, from the point of metabonomics.
Result:
一、Animal experiment study
(1) Comparing with the normal group, the model rat emiction Hippuric acid content 3.97.7.55,7.85, a-Ketoglutarate 3.01,2.45, citrate2.57,4.10,2.88, isocitrate 3.99 2.51 2.45and aconitate 3.77 6.96 3.96 the curve relative integral acreage obviously decrease, and decrease in emiction, Creatinine 3.05,4.07, acetone 2.23, acetic acid 1.93, reatine 3.93,3.03, nicotinate 4.41, 1.41 and acid5-hydroxyindole-3-acetate,5-HIAA 3.03,2.91,6.63, 7.15 the curve relative integral acreage obviously increase, and increase in emiction.
(2) After intervene by Bupleurum smoothing liver medicine, the Metabolic phenotype of group C was reatine 3.93,3.03, acetone 2.23 Creatinine 3.05 the content was obviously decreased, N-TMAO 4.07, TMAO 3.27, aurine 3.43content was obviousaly increased.
(3) From normal group and model group rat blood comparison PCA analysis, the metabolic phenotype of model group is Lactic acid (1.31,1.32,4.11),N-O-GlcNAc(Nac2.02,2.05,2.06,2.09), Choline, saturated fatty acid, B-dextrose(3.47,3.91) increase, unsaturated fatty acid, HDL (0.83), Glu, Gln(2.43) Val (1.03,0.98), VLDL (1.29,0.87), LDL, (1.25,0.85) Lipoid (1.27), content was decreased。The symbol of metabolite may be lactic acid, Choline, NAC, saturated fatty acid, blood sugar, unsaturated fatty acid, HDL。
(4) The rats from Liver Qi Stagnation Syndrome group were treated by Chaihu Shugansan. After the PCA analysis on the blood-lH-NMR spectral peak integral values, the obtained score plot factor loading diagram (loadingplot), and PC integral values distributed on the oval-shaped scatter (95% confidence region) in four regions, but the two groups can not be distinguished, which indicated that the Phenotypic differences in metabolism of blood compounds of model group and treatment group could not be found.
二、clinical study
(1) It can be see from the results of comparative PCA analysis on the urine of normal group and Liver Qi Stagnation patients'group that, Liver Qi Stagnation group's urine metabolic phenotype was: creatinine 3.06,4.06,4.1 rose, citrate 2.57,2.71,2.66, Phe (phenylalanine) 3.12, tryptophan (tryptophan) 3.32, acetyl citric acid (acetyl citric acid) 1.28,1.26, tyramine (tyramine) 2.71,2.53, aconitic acid (aconitic acid) 3.17 3.45,3.77 and other compounds decreased.
(2) It can be seen from the statistical analysis results of the normal group and Liver Qi Stagnation patients'group that, the PCA analysis on two groups of blood plasma metabonomics showed that there is no distinction of PC between the normal group and the group of liver qi stagnation, which indicated that Liver Qi Stagnation Syndrome patients' endogenous metabolism of plasma spectra did not change significantly.
Conclusion
In Liver Qi Stagnation Syndrome, the performance of amino acid metabolism was apparent; citric acid content in urine decreased; creatinine increased; blood lactate concentration increased; glutamic acid, Gln and Screenshot acid declined. The amino acid metabolism differences may be related to liver qi stagnation. Liver Qi Stagnation syndrome is related to energy metabolism, and its compounds include creatinine (ereatinine), lactate (laetate), citric acid (eitrate) and alanine (alanine); Liver Qi Stagnation syndrome is related to neural System Regulation:it was found in the sample patients with the Liver Qi Stagnation Syndrome that a series of metabolites of phenylalanine and tyramine content related with tyrosine metabolism decreased. It was found that Tryptophan may be neural basis for regulating the biological material for Liver Qi Stagnation Syndrome; Liver Qi Stagnation Syndrome group also may have weakened immune function:the metabolites is L-tryptophan metabolism; tryptophan is the Synthesis of 5-HT precursor substance; decrease of tryptophan metabolism resulted in the reduction of 5-HT synthesis; the activation of the sympathetic nervous system regulated the immune system mainly based on suppression, which led to the release of glucocorticoids from the adrenal cortex and the inhibition of immune cells.
From the findings above, the changes of biological foundation of Liver Qi Stagnation Syndrome metabolite were found; the mechanism changes of Liver Qi Stagnation organism' s physiological and pathological basis was obtained. Therefore, the study was a successful exploration of the biological features of Liver Qi Stagnation from an overall perspective of metabolomics.
肝气郁结证的发生非常普遍,是常见的中医内科证型,据中医内科临床住院病例的抽样统计中,大约有21%左右都有肝气郁结证侯的表现。近些年来,对于肝气郁结证本质生物学基础的研究较多,基本上都是单个系统的研究,主要是自主神经功能,分子生物学,微量元素,血液流变学,血浆生化,性激素,脏器损伤与量表测试等方面,至今还少有从多系统方面来研究肝气郁结证生物学基础的,对肝气郁结证目前仍未能够全面整体地阐明其生物学基础,代谢组学是现今生物与医学界的研究热点之一,它可以对各种常见生物体内几乎所有代谢产物进行定量分析,并描述生物体内代谢物动态变化,来发现代谢物变化与生理病理相关的改变关系,通过生物整体、系统或器官代谢途径及内源性代谢物质所受的不同影响因素,来研究机体的整体与全局。
应用代谢组学研究肝气郁结证候,正是中医整体观的具体科学表现。在本研究中,我们一方面利用情志刺激法制作大鼠肝气郁结证模型,并用柴胡疏肝散进行灌胃给药,观察造模及给药前后代谢组的差异变化,另一方面在临床上筛选肝气郁结证患者,通过尿液与血液中代谢物的变化,以期从小分子代谢物组学水平来整体、系统地探讨肝气郁结证的特征代谢表型与可能存在的生物学本质,为肝气郁结证的进一步防治提供相应的理论与实验依据。
方法
30只健康SD大鼠,体重220g,随机分为3组：正常组10只(A组)、模型组10只(B组)和给药组10只(C组),除正常组外,其余组采用夹尾法造模建立大鼠肝气郁结证模型,给药组造模后给予柴胡疏肝散灌胃(0.5g/ml),每天两次,各组分别在造模前一天、成模后、给药后收集尿液与血液,通过NMR波谱仪检测,运用代谢组学的方法,观察大鼠正常与肝气郁结模型以及柴胡疏肝散干预后,尿液与血液小分子代谢物组的差异性变化谱；并通过30例临床肝气郁结证患者与30例健康人的尿液与血液代谢组学观察,从整体性角度来探寻肝气郁结证的生物学基础和生理病理机制。
结果
一、动物实验研究
(1)与正常组相比,模型组肝气郁结证大鼠尿液马尿酸3.97ppm,7.55ppm,7.85ppmα-酮戊二酸3.01ppm,2.45 ppm柠檬酸(citrate)2.57 ppm,4.10 ppm,2.88 ppm异柠檬酸(isocitrate) 3.99 ppm,2.51ppm,2.43和乌头酸(aconitate) 3.77 ppm,6.96 ppm,3.96 ppm的谱峰相对积分面积明显降低,在尿液中含量降低,肌酸酐3.05 ppm,4.07ppm,丙酮2.23 ppm,乙酸1.93 ppm,肌酸3.93 ppm,3.03 ppm,烟酸(nicotinate) 4.41 ppm,1.41 ppm和5-羟基吲哚-3-乙酸(5-hydroxyindole-3-acetate,5-HIAA) 3.03 ppm,2.91 ppm,6.63 ppm,7.15 ppm谱峰相对积分面积显著增高,在尿液中的含量升高。
(2)肝气郁结证大鼠给予柴胡疏肝散干预后,给药组代谢表型为肌酸3.93,3.03,丙酮2.23肌酸酐3.05等含量明显下降,N-氧化三甲胺4.07, TMAO 3.27,牛磺酸3.43等含量明显增高。差异性表达代谢物结果显示,在造模后升高的差异表达代谢物在给予柴胡疏肝散干预后,大多数变化显著性降低或者已无显著性,其尿液代谢表型有向正常范围回归的趋势,呈现代谢网络修复的结果。这提示柴胡疏肝散对肝气郁结模型组大鼠有一定的恢复作用。
(3)从正常组和模型组肝气郁结证大鼠血液的比较代谢主成分分析来看,肝气郁结证大鼠血液代谢表型为不饱和脂肪酸HDL(0.83),谷氨酸G1u,谷氨酰胺G1n(2.43),撷氨酸Va1(1.03,0.98),VLDL(1.29,0.87),LDL,(1.25,0.85)类脂,(1.27)等化合物含量降低,乳酸Lac(1.31,1.32,4.11),N-乙酰糖蛋白Nac(2.02,2.05,2.06,2.09),胆碱,饱和脂肪酸,B-葡萄糖(3.47,3.91)含量上升。其代谢产物标志物可能是乳酸、胆碱、Nac、饱和脂肪酸、血糖、不饱和脂肪酸、HDL。
(4)给药组肝气郁结证大鼠给予柴胡疏肝散干预后,对血液1H-NMR谱峰积分值进行PCA分析后,得到得分图(scoreplot),两组均不能区分开,说明没有找到模型组与给药组的血液代谢表型差异化合物。
二、临床研究
(1)从正常组和肝气郁结证患者组尿液的比较代谢PCA分析来看,肝气郁结证患者尿液代谢表型为柠檬酸(citrate) 2.57,2.71,2.66,苯丙氨酸(phenylalanine) 3.12,色氨酸(tryptophan) 3.32,乙酰基柠檬酸(acetyl citric acid) 1.28,1.26,酪胺(tyramine) 2.71,2.53,乌头酸(aconitic acid) 3.17 3.45,3.77等化合物含量降低,肌酐(creatinine)3.06,4.06,4.1上升。
(2)对正常组与肝气郁结证患者组血液代谢组统计分析,两组血液的代谢组学PCA分析结果可以看出正常组与肝气郁结组之间PC没有区分开来,说明肝气郁结证患者血浆内源性代谢谱变化不明显。
结论
(1)肝气郁结证反应了能量代谢水平偏低,主要代谢途径是三羧酸循环,标志代谢物为柠檬酸和乌头酸的显著性降低。
(2)肝气郁结发生机制“怒伤肝”的生物学基础为烟酸的代谢。
(3)肝气郁结的抑郁症状与色氨酸代谢降低密切相关。
(4)柴胡疏肝散能够部分调控平抑肝气郁结证中发生异常的代谢产物。
(5)“肝主疏泄”对情志的调节作用通过酪氨酸代谢发挥作用。
(6)在肝气郁结证候中氨基酸代谢表现明显。
通过以上发现的肝气郁结证候代谢产物发生变化的生物基础,得到肝气郁结证生物体生理与病理发生的代谢组变化机制,对肝气郁结证的生物特征从代谢组学整体角度进行了成功的探索。
意义：初步发现肝气郁结证生物体的生理与病理发生变化的代谢机制基础是具有整体特征的多个代谢途径。
Objective:
The stagnation of Liver-Qi syndrome is a very far-ranging and pervasive syndrome, and also a familiar TCM (Traditional Chinese Medicine) internal medicine syndrome. According to sample statistic of TCM internal medicine history cases, around 21% patient get the stagnation of Liver-Qi syndrome. Recent years, entitative biological study to the stagnation of Liver-Qi syndrome is basically study of single system, which covers aspects of Blood Biochemical, autonomic nerve function, Trace Element Level, Blood rheology study, molecular biology, sex hormone, Damage of Organs, and Parametric Testing, etc., but few study is based on multi-system aspect. There is no illustrated biological foundation for the stagnation of Liver-Qi syndrome. Metabonomics is nowdays hot topic in biology and iatrology, which is used as quantitative analysis for almost all metabolites of all kinds of familiar organism, and describe the parameter dynamic change of metabolites, in order to find the relationship of metabolites change and pathophysiology, so that to study the macrocosm and the all, through studying different effect factor of the whole-body system, system and Apparatus etabolism approach and Endogenous etabolism matter. It is a representation of Tradicitional Chinese Medicine Holism, that apply metabonomics to The stagnation of Liver-Qi syndrome. In this study, on the one hand we use emotion stimulating and pinching the tail method to make rat model of stagnation of Liver-Qi syndrome, and intervent by Bupleurum smoothing liver medicine, observe the modification before and after take the medicin. On the other hand, the cilinic aspect, we choose patients with Ganqi stagnation, observe the change of emiction and blood metabolite, from the point of metabonomics, to holistic expound the biological fundation of stagnation of Liver-Qi syndrome, in order to analysis the Phenotype Characteristics and possible biological fundation of the stagnation of Liver-Qi sydrome, from a systemic and holistic Small molecule metabonomics level, and also provide relavant theory and experiment support for further prevention for the stagnation of Liver-Qi syndrome.
Method:
30 healthy SD rat, body weight 220g, divide to three groups by chance:Group A:Normal 10; Group B:model group 10; Group C: medicine group 10. Except for group A, the other two groups was made into model of the stagnation of Liver-Qi syndrome. Group C was provided Bupleurum smoothing liver medicine,0.5g/mL, twice per day. All groups is to collect emiction and blood samples the day before modelling, after modeling, and after take the medicine, go through NMR Spectrometer examination, and use metabonomics method, after observe group A, B and C, the change of emiction and blood Small-molecule metabolites, and meanwhile observe emiction and blood metabonomics study of 30 clinical patients with Ganqi stagnation and 30 healthy people, and study the biological fundation and pathophysiology, from the point of metabonomics.
Result:
一、Animal experiment study
(1) Comparing with the normal group, the model rat emiction Hippuric acid content 3.97.7.55,7.85, a-Ketoglutarate 3.01,2.45, citrate2.57,4.10,2.88, isocitrate 3.99 2.51 2.45and aconitate 3.77 6.96 3.96 the curve relative integral acreage obviously decrease, and decrease in emiction, Creatinine 3.05,4.07, acetone 2.23, acetic acid 1.93, reatine 3.93,3.03, nicotinate 4.41, 1.41 and acid5-hydroxyindole-3-acetate,5-HIAA 3.03,2.91,6.63, 7.15 the curve relative integral acreage obviously increase, and increase in emiction.
(2) After intervene by Bupleurum smoothing liver medicine, the Metabolic phenotype of group C was reatine 3.93,3.03, acetone 2.23 Creatinine 3.05 the content was obviously decreased, N-TMAO 4.07, TMAO 3.27, aurine 3.43content was obviousaly increased.
(3) From normal group and model group rat blood comparison PCA analysis, the metabolic phenotype of model group is Lactic acid (1.31,1.32,4.11),N-O-GlcNAc(Nac2.02,2.05,2.06,2.09), Choline, saturated fatty acid, B-dextrose(3.47,3.91) increase, unsaturated fatty acid, HDL (0.83), Glu, Gln(2.43) Val (1.03,0.98), VLDL (1.29,0.87), LDL, (1.25,0.85) Lipoid (1.27), content was decreased。The symbol of metabolite may be lactic acid, Choline, NAC, saturated fatty acid, blood sugar, unsaturated fatty acid, HDL。
(4) The rats from Liver Qi Stagnation Syndrome group were treated by Chaihu Shugansan. After the PCA analysis on the blood-lH-NMR spectral peak integral values, the obtained score plot factor loading diagram (loadingplot), and PC integral values distributed on the oval-shaped scatter (95% confidence region) in four regions, but the two groups can not be distinguished, which indicated that the Phenotypic differences in metabolism of blood compounds of model group and treatment group could not be found.
二、clinical study
(1) It can be see from the results of comparative PCA analysis on the urine of normal group and Liver Qi Stagnation patients'group that, Liver Qi Stagnation group's urine metabolic phenotype was: creatinine 3.06,4.06,4.1 rose, citrate 2.57,2.71,2.66, Phe (phenylalanine) 3.12, tryptophan (tryptophan) 3.32, acetyl citric acid (acetyl citric acid) 1.28,1.26, tyramine (tyramine) 2.71,2.53, aconitic acid (aconitic acid) 3.17 3.45,3.77 and other compounds decreased.
(2) It can be seen from the statistical analysis results of the normal group and Liver Qi Stagnation patients'group that, the PCA analysis on two groups of blood plasma metabonomics showed that there is no distinction of PC between the normal group and the group of liver qi stagnation, which indicated that Liver Qi Stagnation Syndrome patients' endogenous metabolism of plasma spectra did not change significantly.
Conclusion
In Liver Qi Stagnation Syndrome, the performance of amino acid metabolism was apparent; citric acid content in urine decreased; creatinine increased; blood lactate concentration increased; glutamic acid, Gln and Screenshot acid declined. The amino acid metabolism differences may be related to liver qi stagnation. Liver Qi Stagnation syndrome is related to energy metabolism, and its compounds include creatinine (ereatinine), lactate (laetate), citric acid (eitrate) and alanine (alanine); Liver Qi Stagnation syndrome is related to neural System Regulation:it was found in the sample patients with the Liver Qi Stagnation Syndrome that a series of metabolites of phenylalanine and tyramine content related with tyrosine metabolism decreased. It was found that Tryptophan may be neural basis for regulating the biological material for Liver Qi Stagnation Syndrome; Liver Qi Stagnation Syndrome group also may have weakened immune function:the metabolites is L-tryptophan metabolism; tryptophan is the Synthesis of 5-HT precursor substance; decrease of tryptophan metabolism resulted in the reduction of 5-HT synthesis; the activation of the sympathetic nervous system regulated the immune system mainly based on suppression, which led to the release of glucocorticoids from the adrenal cortex and the inhibition of immune cells.
From the findings above, the changes of biological foundation of Liver Qi Stagnation Syndrome metabolite were found; the mechanism changes of Liver Qi Stagnation organism' s physiological and pathological basis was obtained. Therefore, the study was a successful exploration of the biological features of Liver Qi Stagnation from an overall perspective of metabolomics.
引文
[1]谢宇霞.肝气郁结相关因素的流行病学研究[J].中国中医药现代远程教育,2009,7(2)：5
[2]严灿,高敏,张新春,等.肝郁证免疫机能改变机制的临床与实脸研究[J].中医研究,1995,8(6)：18-20
[3]陈泽奇,金益强,陈国林,等.肝气郁结证血浆去甲肾上膝素和肾上腺素测定结果分析[J].中医药学报,1997,25(5)：47-48
[4]乔明琦,张惠云,陈雨振,等.肝郁证动物模型研究理论思考[J].中国医药学报,1997,12(5)：42-49
[5]陆明霞,陈乃明.针刺舒肝理气法研究[J].山东中医药大学学报,1999,23(1)：30-33
[6]侯淑英,朱宏安,宁丽.肝郁气滞型胆结石患者胆汁粘度的观察[J].中国中西医结合杂志,1996,8(6)：18-20
[7]陈泽奇,陈国林,李学文,等.肝气郁结证患者血浆抗利尿激素的变化[J].华人消化杂志,1998,6(6)：495-496
[8]陈泽奇,陈国林,石林附,等.肝气郁结证患者血浆L-ENK,AVP,ANP含量分析[J].湖南中医学院学报,1997,17(3),37-39
[9]陈泽奇,李学文,陈国林,等.肝气郁结证患者血清胃泌素含t分析[J].湖南中医学院学报,1998,18(1)：3-4
[10]王霞灵,周大桥,李延福.肝郁患者雌激素水平研究[J].湖北中医杂志,1996,18(4)：38-39
[11]程化奇,熊舜华,陈友香,等.女性更年期综合征阴虚阳亢证与肝郁气滞证宏观辨证与微观辨证研究[J].新中医,1997,29(1),36-39
[12]贾可夫,王希浩,宋红湘,等.舒肝法对肝郁证月经病血清PRL, EZ, P, EZ/P作用的研究[J].实用中西医结合杂志,1995,8(2),110-111
[13]殷燕方.逍遥散加味治疗经前期紧张综合征45例[J].南京中医药大学学报,1999,15(2)：84-85
[14]俞亚琴,郭合钧.肠道易激征患者的中医辨证与微量元素关系的实验研究.[J].中医药研究,1997,13(4)：46
[15]柴丽娜,杜惠兰.肝郁型月经病血液流变学及盆腔血流图的观察与分析.[J].山东中医杂志,1997,16(2)：61-62
[16]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[17]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition [J]. NMR in Biomedicine,2005,18:143-162
[18]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo-nomics: metabolic processes studied by NMR spectroscopy of biofluids[J]. Concepts Magn Resort,2000,12(5):289-320.
[19]German J B, Bauman D E, Burrin D G, et al. Metabolomics in the opening decade of the 21st century:building the roads to individualized health [J]. Nutrue,2004,134(10):2729
[20]Lindon J C, Holmes E, Nicholson J K:Recent Developments and Applications of NMR-Based Metabonomics[J].波谱学杂志Vol.23 No.1Mar.2006
[1]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites andisotopomers by NMR[J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[2]须惠仁.肝气郁结证的动物实验研究[J].中医杂志,1991,6：44
[3]陈小野.实用中医证候动物模型学[M].北京：北京医科大学、协和医科大学联合出版社,[J]1993,160-261
[4]聂丹丽.胃动灵对肝郁、脾虚大鼠模型胃肠运动影响的实验研究[J].陕西中医,2000；21(6)：25-28
[5]Waters NJ, Waterfield CJ, Farrant RD,et al.Metabo-nomic deconvolution of embedded toxicity:applicationto thioace tamide hepato-and nephrotoxicity[J]. Chem ResToxicol.2005; 18(4): 639-654.
[6]Lindon JC, Nicholson JK, Holmes E, et al.Metabo-nomics: metabolic processes studied by NMR spectros-copy of biofluids [J]. Concepts Magn Reson.2000; 12 (5):289-320.
[7]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approachesfor evaluating physiological influences on biofluid composition[J]. NMR Biomed,2005,18:143-162.
[8]Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applicationsin biomedical magnetic resonance[J]. Prog Nucl Magn Reson Spectrosc,2001,39(1):1-40.
[9]Jun Yang, Guowang Xu, Yufang Zheng. Strategy formetabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry [J]. Journal of chromatographya,2005,1084:214-221.
[10]Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of presenceand severity of coronary heart disease using 1H-NMR-based metabonomics[J]. NATMED,2002,8(12):1439-1444.
[11]Holmes E, Vicholson JK, Tranter G.. Metabononuc classification of geneticvariations in toxicological and metabolic responses using probabalistic neuralnetworks[J]. Chem Res Toxicol,2001,14 (2):182-191.
[12]Nicholson J K. Global systems biology, personalized medicine and molecular epidemiology [J]. Mol Systems Biol,2006,2:52
[13]Kulinskii VI, Medvedev AI, Kuntsevich AK. [Stimulation of mitochondrial oxidative enzymes in acute cooling and its catecholamine mechanisms] [J]. Vopr Med Khim.1986,32 (5):84-8.
[14]Lapsha Ⅵ, Ekimova Ⅳ. [Cytophotometric study of catecholamines and energy metabolism enzymes in the neurons of the rat celiac plexus during cold and emotional stresses] [J]. Neirofiziologiia.1988,20 (6):743-9.
[15]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites and isotopomers by NMR[J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[16]Balkan J, Kanbaglii O, Aykag-tokijr G. et al.Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[17]Fedyk M, Velykyi MM, Zababurina ML, et al. [The dynamic biosynthesis of nicotinamide coenzymes from nicotinamide and nicotinic acid in rat tissues] [J]. Ukr Biokhim Zh.1996,68 (2):29-33.
[18]Yoshimatsu H, Tsuda K, Niijima A, et al. Histidine induces lipolysis through sympathetic nerve in white adipose tissue [J]. Eur J Clin Invest.2002,32 (4):236-41.
[19]Martineau L, Jacobs I. Effects of muscle glycogen and plasma FFA availability on human metabolic responses in cold water [J]. J Appl Physiol.1991,71 (4):1331-9.
[1]Waters NJ, Waterfield CJ, Farrant RD, et al.Metabo-nomic deconvolution of embedded toxicity:applicationto thioacetamide hepato-and nephrotoxicity[J]. Chem ResToxicol.2005; 18(4): 639-654.
[2]Lindon J C, Holmes E, Nicholson J K. Recent Developments and Applications of NMR-Based Metabonomics [J]. 波普学杂志,2006,11 (2):23
[3]Assy N, Kaita K, Mymin D, et al. Fatty infiltration of liver in hyperlipidemic patients [J]. DigDisSci,2000,45 (10):1929-1934.
[4]Marchesini G, Brizi M, Bianchi G, et al. Nonacoholic fatter liver disease:a featureof the metabolic syndrom[J]e. Diabetes,2001,50 (8):1844-1850.
[5]Bello-Ramirez AM, Nava-Ocampo AA. A QSAR analysis of toxicity of Aconitumalkaloids[J].Fundam Clin Pharmacol,2004,18 (6):699-704.
[6]Raamsdonk L M, Teusink B, Broahurst D, et al. A functional genomics strategy that uses melaholome data to reveal the phenptype of silent mutations [J]. Nat Biotedi,2001,19 (3):45-50.
[7]吕志平,刘承才.“肝郁”大鼠的脂质过氧化反应及逍遥散的保护作用[J].山东中医学院学报,1995(3)：199-201
[8]Balkan J,Kanbaglii O, Aykag-toki jr G., et al.Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[9]Nandhini A T, Balakrishnan S D, Anuradha C V. Response of liver antioxidant system to taurine in rats fed high fructose diets [J]. Indian J Exp Biol,2002,40(9):1016-1024.
[10]Wu C, Kennedy D 0, Yano Y, et al.Thiols and polyamines in the cytoprotective effect of taurine on carbon tetrachloride induced hepato-toxicity[J]. J Biochem Mol Toxicol,1999,13(2):71-76.
[11]Nicholls AW,Mortishire-Smith RJ, Nicholson JK, et al.NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats [J]. Chem Res Toxicol,2003, 16(11):1395-1404.
[12]MinjunChen, Liping Zhao, Weijia, et al. Metabonomic study on the biochemical profile of hydrocortisone induced anilmal model [J]. Joumal of Proteme Research,2005,4 (6):2391-2396
[13]李中峰，昊惠丰,张晓宇,等.轻稀土镧、铈急性生物效应的血清1H-NMR谱代谢组学研究[J].高等学校化学学报,2006,27：438-442.
[14]Holmes E,Nicholls AW, Lindon JC,et al.Development of a model for classification of toxin-induced lesions using 1H NMR spectr oscopy of urine combined with pattern recognition[J]. NMR Biomed. 1998,11:235-246.
[15]Minju Chen, Liping Zhao, Jianjiang, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats [J]. Jourmal of proteme Research,2006,5 (4):95-100
[16]Hensley K, Kotake Y, Sang H, et al. Dietary choline restriction causes Compels Idysfunction and increased H2O2 generation in liver mitochondr[J]a. Carcinogenesis,2000,21:983-989.
[1]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi-systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[2]LU Yi-hong, HAO Hai-ping, WANG Guang-ji, ea tl. Chinese Pharmacological Society [J]. Chinese Pharmacological Society,2007, 12(10):1144-1150
[3]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo—nomics: metabolic processes studied by NMR spectroscopy of biofluids [J]. Concepts Magn Resort,2000,12(5):289-320.
[4]Nicholson JK, Foxall PJ, Spraul M, Farrant RD, LindonJC.750 H NMR spectroscopy of humanblood plasma [J]. Aria/Chem,1995,67 (5): 793-811.
[5]Constantinou M A, Papakonstantinon E, Sprawl M, et al. 1H-NMR based metabonomics for the diagnosis of inborn errors of metabolism in urine[J]. Analytica Cbimica Acta,2005,542 (2): 169-177.
[6]罗和古丁杰.大鼠肝郁脾虚的代谢组学研究[J].中西医结合学报,2007，5，(3)：307
[7]徐舒,陈合兵,李洪等.“肝郁证”大鼠模型的建立及代谢组学的初步研究[J].中华中医药杂志,2009,6(34)：6
[8]. ChuangCK, LinSP, ChenHH, etal. Plasmafree aminoacids and their metabolitesin Taiwanese Patienison hemodialy sisandeontinuou sambulatory Peritonealdialysis [J].Clin Chim Aeta.2006, 364(12):209-216
[9]Tang H R, Wang Y L. Metabonomics:arevo lutionin progress [J]. Prog Biochem Biophys,2006,33(5):401-417
[1]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[2]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo—nomics: metabolic processes studied by NMR spectroscopy of biofluids[J]. Concepts Magn Resort,2000,12(5):289-320.
[3]Nicholson JK, Foxall PJ, Spraul M, Farrant RD, LindonJC.750 H and H-OC NMR spectroscopy of humanblood plasma [J]. Aria/Chem, 1995,67(5):793-811.
[4]El-Deredy W. Pattern recognition approaches in biomedicaland clinical magnetic II solmnce spectros copy:a review[J]. NMR B/ omed,1997,10(3):99-124.
[1]陈锦锋,王爱成,王玉来,等.肝气郁结证诊断的必备症状以及与抑郁状态的关系探讨[J].辽宁中医杂志,2005,32(1)：19-23
[2]骆抗先,毛乾国.慢性乙型肝炎的治疗[J].临床肝胆病杂志,2004,20 (4)：70.
[3]Emmet B. keeffe, Douglas T. dieterich, Steve-huy B. han,et al. A t reatment algorit hm for t he management of chronic hepatitis B virhs infection in t he united states [J]. Clinic Gast roenterology and Hepa tology,2004,2 (2):87.
[4]全国病毒性肝炎学术组.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1)：56-62
[5]盛国平.基于GC-MS和LC-MS技术的肝病代谢组学研究[C].浙江大学博士论文,2008年4月
[6]Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states [J]. Psychosom Med.2003,65 (4):665-71.
[7]陈泽奇陈国林金益强等. 肝气郁结证病理生理学基础研究[J].中国现代医学杂志,2000,10(10)：21
[8]HeilSA, Wiehems C, MossnerR, etal. Functional Eharaeterization of them urineser otonintrans Portergene Promoterin Sero-tonergiera Pheneurons[J]. J Neuroehem,1998,70(3):932-939
[9]Ellis PM, Salmond C. Imipramineb indingin depression:A Meta-analysis[J]. BiolPsychiatry,1994,36(5):292-299
[10]Holmes E, Tang H R, Wang Y L, et al. The assessment of plant metabolite profiles by NMR-based methodologies [J]. Plant Med, 2006,72(9):771-785
[1].PostieC, DentinR, GirardJ.Role of the liver in the eonirol of earbohy drate and liPidho meostasis [J]. Diabete sMetab.2004, 30(5):398-408.
[2]Raamsdonk L M, Teusink B, Broahurst D, et al. A functional genomics strategythat uses melaholome data to reveal the phenptype of silent mutations[J]. Nat Biotedi,2001,19 (3):45-50
[3]Bello-Ramirez AM, Nava-Ocampo AA. A QSAR analysis of toxicity of Aconitumalkaloids[J].Fundam Clin Pharmacol,2004,18 (6):699-704..
[4]王晓艳,应激及其药物干预的代谢组学研究[A].上海交通大学博士论文,2007年7月
[5]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites andisotopomers by NMR [J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[6]Fedyk M, Velykyi MM, Zababurina ML, et al. [The dynamic biosynthesis of nicotinamide coenzymes from nicotinamide and nicotinic acid in rat tissues [J].Ukr Biokhim Zh.1996,68 (2): 29-33.
[7]Martineau L, Jacobs I.Effects of muscle glycogen and plasma FFA availability on human metabolic responses in cold water [J]. J Appl Physiol.1991,71 (4):1331-9.
[8]Yoshimatsu H, Tsuda K, Niijima A, et al. Histidine induces lipolysis through sympathetic nerve in white adipose tissue [J]. Eur J Clin Invest.2002,32 (4):236-41.
[9]Balkan J, Kanbaglii O, Aykag-toki jr G., et al.Taurine treatment reduces hepaticlipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[10]Nandhini A T, Balakrishnan S D, Anuradha C V. Response of liver antioxidantsystem to taurine in rats fed high fructose diets [J]. Indian J Exp Biol,2002,40(9):1016-1024.
[11]Wu C, Kennedy D O, Yano Y, et al.Thiols and polyamines in the cytoprotectiveeffect of taurine on carbon tetrachloride induced hepato-toxicity[J].J Biochem Mol Toxicol,1999,13 (2):71-76.
[12]李中峰,昊惠丰,张晓宇,等.轻稀土镧、铈急性生物效应的血清1H-NMR谱代谢组学研究[J].高等学校化学学报,2006，27：438-442.
[13]Holmes E,Nicholls AW, Lindon JC,et al.Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition[J]. NMR Biomed.1998,11:235-246.
[14]罗和古丁杰徐舒,陈合兵,李洪等.大鼠肝郁脾虚的代谢组学研究[J].中西医结合学报,2007,5(3)：307
[15]. ChuangCK, LinSP, ChenHH, etal. Plasma free aminoacids and their Metabolites in Taiwan ese Patienison hemodialysis and eontinuous ambulatory Peritonealdialysis [J].Clin Chim Aeta.2006, 364(12):209-216
[16]徐舒陈合兵李洪等.“肝郁证”大鼠模型的建立及代谢组学的初步研究[J].中华中医药杂志,2009, (6)：787-791
[17]Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states [J]. Psychosom Med.2003,65 (4):665-71.
[18]owens MJ, Nemeroff CB. Theroleofserotonin in the PathoPhysi ology of depression:Foeus ontheser otonintrans Porter [J].Clin Chem,1994,40(2):288-295
[19]陈泽奇陈国林金益强等.肝气郁结证病理生理学基础研究[J].中国现代医学杂志,2000,10(10)：12
[1]Nicholson J K,Lindon J C,Holmes E.'Metabonomics':understanding the metabolic responses of living systems to pathoph-ysiologieal stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica,1999 29(11):1181-1189
[2]Fiehn. Metabolomics-the link between genotypes and phenotypes [J]. Plant Mol Biol,2002,48(1-2):155-171
[3]张杰,李涢.关于中医证候物质基础研究路径的思考[J].中国中医基础医学杂志,2007,13(5)：394
[4]李翰旻,毛树松.中医证候信息学[J]中华中医药学刊2008,7,(26)：1374-1378
[5]蒋功成.系统生物医学与中医现代化[J].医学与哲学,2006；27(12)：13-29
[6]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition [J]. NMR in Biomedicine, 2005,18:143-162
[7]B. Teusink, F. Baganz, H. V. Westerhoff, et al. Metabolic control analysis as a tool in the elucidation of the function of novel genes [J]. Methods in Microbiology,1998,26:297-336
[8]German J B, Bauman D E, Burr in D G, et al. Metabolomics in the opening decade of the 21st century:building the roads to individualized health [J]. Nutrue,2004,134(10):2729
[9]Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1 H-NMR-based metabonomics [J]. Nature Medicine, 2002,8(12):1439-1444
[10]Jun Yang, Guowang Xu, Yufang Zheng. Strategy formetabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry [J]. Journal of chromatographya,2005,1084:214-221.
[11]Nicholson J K, Wilson I D. Understanding "global" systems biology:Mctabonomics and the continuum of metabolism[J]. Nat Rev Drug Discov,2003,2(8):668-676
[12]Hood L, Heath J R, Phelps M E, et al. Systemsbiology and new technologies enable predictive and preventative medicine [J]. Science,2004,306(5296):640-643
[13]Nicholson J K. Global systems biology, personalized medicine and molecular epidemiology [J]. Mol Systems Biol,2006,2:52
[14]陈竺.系统生物学--21世纪医学和生物学发展的核心驱动力[J].世界科学,2005,(3)：4-5
[15]Lindon J C, Holmes E, Nicholson J K. Recent Developments and Applications of NMR-Based Metabonomics [J].波普学杂志,2006, 11(2):23
[16]MinjunChen, Liping Zhao, Weijia, et al. Metabonomic study on the biochemical profile of hydrocortisone induced anilmal model [J]. Joumal of Proteme Research,2005,4(6):2391-2396
[17]Minju Chen, Liping Zhao, Jianjiang, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats [J]. Jourmal of proteme Research,2006,5(4):95-100
[18]王米渠,冯韧,严石林,等.基因表达谱芯片与中医寒证的7类相关基因[J].中医杂志,2003,44(4)：288
[19]杨丽萍,陆明,王米渠,等.免疫代谢类基因差异表达评价肾阳虚骨关节炎个案疗效[J].河南中医,2004,17(9)：1
[20]王米渠.肾虚证的基因组与信息融合的研究前瞻-中医科研前言进取功能基因组[J].亚太生技,2004,2(1)：43
[21]李林,王建农,任建勋,等.气虚血瘀证大鼠尿液的核磁共振谱代谢组学[J].科学通报,2007,52(15)：1758
[22]罗和古,丁杰,岳广欣,等.大鼠肝郁脾虚证的代谢组学研究[J].中西医结合学报,2007,5(3)：307
[23]郑丽红.脾气虚证唾液代谢组学的初步研究[A].广州中医药大学硕士学位论文,2007,5
[24]童宁宁.慢性胃炎湿热蕴脾证唾液代谢组学的初步研究[A].广州中医药大学,硕士学位论文,2006；4
[25]LU Yi-hong, HAO Hai-ping, WANG Guang-ji, ea tl. Chinese Pharmacological Society[J]. Chinese Pharmacological Society, 2007,12(10):1144-1150
[26]Arthur JM, Thongboonkerd V, Scherzer JA, et al. Differential ex2 pression of proteins in renal cortex and medulla:a proteomic ap2 proach[J]. Kidny Int,2002,62(8):1314-1318
[27]Tang H R, Wang Y L. Metabonomics:arevolutioninprogress [J]. Prog Biochem Biophys,2006,33(5):401-417
[28]Holmes E, Tang H R, Wang Y L, et al. The assessment of plant metabolite profiles by NMR-based methodologies [J]. Plant Med,2006,72(9):771-785
[1]陆明霞,陈乃明.针刺疏肝理气法研究[J].山东中医药大学学报,1999,23(1)：30.
[2].谢小冰,张问渠.高血压病肝郁证5-羟色胺变化的探讨[J].云南中医杂志,1987,8(4)：4-5
[3].乔明琦,张珍玉.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16：23-26
[4].王霞灵,周大桥.肝郁患者血清泌乳素测定临床意义探讨[J].湖北中医杂志,1995,17(5)：53-54
[5].王希浩,刘明,张萍,等.肝郁型月经病与血清泌乳素水平关系的研究[J].中医研究,1992,5(2)：26-28
[6].文哲双,王志忠,朱毅.肝郁患者血清T、E2、PRL水平检测及其临床意义[J].湖中医学院学报,2000,2(2)：27-29
[7].王霞灵,周大桥,李延福.肝郁患者雌激素水平研究[J].湖北中医杂志,1996,18(4)：38-39
[8].王希浩,贾可夫,何玉凡.从内分泌学探讨肝郁证月经病病理机制[J].实用中西医结合杂志,1995,8(12)：757-758、
[9].黄晖,傅贞亮,董笃一,等.中医肝病124例血清甲状腺激素的观察[J].中医杂志,1992,33(10)：40-42
[10]严灿,张新春,邓中炎.肝主疏泄免疫学机制的临床与实验研究[J].中国中医基础医学杂志,1995,1(3)：37
[11]严灿,邓中炎,王剑.调肝方药对慢性束缚应激大鼠神经内分泌免疫功能的影响[J].中国免疫学杂志,2000,(16)：488-490
[12]严灿,高敏,张新春,等.肝郁证免疫机能改变机制的临床与实验研究[J].中医研究,1995,8(6)：18-20.
[13]陈松,李家邦,朱双罗,等.肝郁证T、B淋巴细胞活性改变及疏肝治疗影响的实验研究[J].湖南中医学院学报,2001,21(2)：7-8
[14]许辉,陈松,李家邦,等.特异性免疫应答在肝郁证与脾虚证及相互关系的初步研究[J].中国医师杂志,2002,4(8)：829-834
[15]陈泽奇,陈国林,石林阶,等,肝气郁结证患者血浆L-NEK、AvP、ANP含量分析[J],湖南中医学院学报,1997,17(3)：37-39
[16]陈泽奇,陈国林,李学文,等,肝气郁结证患者血浆抗利尿激素的变化[J].华人消化杂志,1998,6(6)：495-496
[17]文哲双,王志忠,朱毅.肝郁患者血清T、E2、PRL检测及其临床意义[J].湖北中医药大学学报,2000,2(2)：27-29
[18]常德贵,王峥屹,祝彼得,等.疏肝理气活血法对肝郁气滞大鼠阴茎海绵体PDE5活性影响的实验研究[J].中华男科学,2004,10(1)：71-73
[19]1张向渠,等.高血压病肝郁证的临床研究[J].中西医结合杂志,1987,7(7)：396
[20]陈建伟,李祥,陈进,等.正常人与肝气郁结证人指甲中无机元素的比较分析[J].广东微量元素科学,2001,8(11)：34-37
[21]俞亚琴,郭合钧,肠道易激征患者的中医辨证与微量元素关系的实验研究[J].中医药研究,1997,13(4)：46
[22]黎杏群,等.肝阳上亢证患者血浆血栓素B2和6-酮-前列腺素F1[J].湖南医学院学报,1989,14(1)：43-45
[23]杨冬花,李家邦,郑爱华,等.肝气郁结证模型大鼠Th1：/Th2细胞因子变化及柴胡疏肝散的干预作用[J].湖南中医学院学报,2003,23(5)：4-7
[24]郑爱华,李家邦,蔡光先,等.柴胡疏肝散、四君子汤对肝郁、脾虚病人Th细胞分化信号蛋白PKC表达的影响[J].贵阳中医学院学报,2003,25(4)：14-17
[25]崔向阳,等。.60例肝郁气滞及相关证候病人的血液流变性变化的初步研究[J].黑龙江中医药,1989,(5)：49
[26]金益强,中医肝脏象现代研究与临床[M].第1版,人民卫生出版社,2000：16-18
[27]李爱中,等.60例肝郁气滞及其相关证候病人的甲襞微循环变化浅析[J].黑龙江中医药,1989,(5)：50-51
[28]陈泽奇,等.肝风内动证患者球结膜微循环状态研究[J].现代医学杂志,1992,2(1)：12-14
[29]朱双罗,等.中医肝病不同证型患者个性特征的研究[J].当代医师杂志,1997,2(3)：15-17
[30]黄炳山,等.肝郁气滞证A型性格黑[J].龙江中医药,1989,(5)：24
[31]施和勋,肝气郁结患者症状自评量表(SCL-90)评定结果分析[J].浙江中西医结合杂志,1999,9(2)：85-86
[32]吴涛,胡随瑜,肝气郁结证患者情绪状态的评估与血浆神经降压素水平的Q初步研究[J].湖南中医学院院报,2001,21(3)：5-13
[33]陈泽奇,胡随瑜,刘盛,肝气郁结证患者焦虑\抑郁测量结果分析[J].湖南中医学院学报,2000,20(1)：4-5
[2]严灿,高敏,张新春,等.肝郁证免疫机能改变机制的临床与实脸研究[J].中医研究,1995,8(6)：18-20
[3]陈泽奇,金益强,陈国林,等.肝气郁结证血浆去甲肾上膝素和肾上腺素测定结果分析[J].中医药学报,1997,25(5)：47-48
[4]乔明琦,张惠云,陈雨振,等.肝郁证动物模型研究理论思考[J].中国医药学报,1997,12(5)：42-49
[5]陆明霞,陈乃明.针刺舒肝理气法研究[J].山东中医药大学学报,1999,23(1)：30-33
[6]侯淑英,朱宏安,宁丽.肝郁气滞型胆结石患者胆汁粘度的观察[J].中国中西医结合杂志,1996,8(6)：18-20
[7]陈泽奇,陈国林,李学文,等.肝气郁结证患者血浆抗利尿激素的变化[J].华人消化杂志,1998,6(6)：495-496
[8]陈泽奇,陈国林,石林附,等.肝气郁结证患者血浆L-ENK,AVP,ANP含量分析[J].湖南中医学院学报,1997,17(3),37-39
[9]陈泽奇,李学文,陈国林,等.肝气郁结证患者血清胃泌素含t分析[J].湖南中医学院学报,1998,18(1)：3-4
[10]王霞灵,周大桥,李延福.肝郁患者雌激素水平研究[J].湖北中医杂志,1996,18(4)：38-39
[11]程化奇,熊舜华,陈友香,等.女性更年期综合征阴虚阳亢证与肝郁气滞证宏观辨证与微观辨证研究[J].新中医,1997,29(1),36-39
[12]贾可夫,王希浩,宋红湘,等.舒肝法对肝郁证月经病血清PRL, EZ, P, EZ/P作用的研究[J].实用中西医结合杂志,1995,8(2),110-111
[13]殷燕方.逍遥散加味治疗经前期紧张综合征45例[J].南京中医药大学学报,1999,15(2)：84-85
[14]俞亚琴,郭合钧.肠道易激征患者的中医辨证与微量元素关系的实验研究.[J].中医药研究,1997,13(4)：46
[15]柴丽娜,杜惠兰.肝郁型月经病血液流变学及盆腔血流图的观察与分析.[J].山东中医杂志,1997,16(2)：61-62
[16]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[17]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition [J]. NMR in Biomedicine,2005,18:143-162
[18]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo-nomics: metabolic processes studied by NMR spectroscopy of biofluids[J]. Concepts Magn Resort,2000,12(5):289-320.
[19]German J B, Bauman D E, Burrin D G, et al. Metabolomics in the opening decade of the 21st century:building the roads to individualized health [J]. Nutrue,2004,134(10):2729
[20]Lindon J C, Holmes E, Nicholson J K:Recent Developments and Applications of NMR-Based Metabonomics[J].波谱学杂志Vol.23 No.1Mar.2006
[1]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites andisotopomers by NMR[J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[2]须惠仁.肝气郁结证的动物实验研究[J].中医杂志,1991,6：44
[3]陈小野.实用中医证候动物模型学[M].北京：北京医科大学、协和医科大学联合出版社,[J]1993,160-261
[4]聂丹丽.胃动灵对肝郁、脾虚大鼠模型胃肠运动影响的实验研究[J].陕西中医,2000；21(6)：25-28
[5]Waters NJ, Waterfield CJ, Farrant RD,et al.Metabo-nomic deconvolution of embedded toxicity:applicationto thioace tamide hepato-and nephrotoxicity[J]. Chem ResToxicol.2005; 18(4): 639-654.
[6]Lindon JC, Nicholson JK, Holmes E, et al.Metabo-nomics: metabolic processes studied by NMR spectros-copy of biofluids [J]. Concepts Magn Reson.2000; 12 (5):289-320.
[7]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approachesfor evaluating physiological influences on biofluid composition[J]. NMR Biomed,2005,18:143-162.
[8]Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applicationsin biomedical magnetic resonance[J]. Prog Nucl Magn Reson Spectrosc,2001,39(1):1-40.
[9]Jun Yang, Guowang Xu, Yufang Zheng. Strategy formetabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry [J]. Journal of chromatographya,2005,1084:214-221.
[10]Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of presenceand severity of coronary heart disease using 1H-NMR-based metabonomics[J]. NATMED,2002,8(12):1439-1444.
[11]Holmes E, Vicholson JK, Tranter G.. Metabononuc classification of geneticvariations in toxicological and metabolic responses using probabalistic neuralnetworks[J]. Chem Res Toxicol,2001,14 (2):182-191.
[12]Nicholson J K. Global systems biology, personalized medicine and molecular epidemiology [J]. Mol Systems Biol,2006,2:52
[13]Kulinskii VI, Medvedev AI, Kuntsevich AK. [Stimulation of mitochondrial oxidative enzymes in acute cooling and its catecholamine mechanisms] [J]. Vopr Med Khim.1986,32 (5):84-8.
[14]Lapsha Ⅵ, Ekimova Ⅳ. [Cytophotometric study of catecholamines and energy metabolism enzymes in the neurons of the rat celiac plexus during cold and emotional stresses] [J]. Neirofiziologiia.1988,20 (6):743-9.
[15]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites and isotopomers by NMR[J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[16]Balkan J, Kanbaglii O, Aykag-tokijr G. et al.Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[17]Fedyk M, Velykyi MM, Zababurina ML, et al. [The dynamic biosynthesis of nicotinamide coenzymes from nicotinamide and nicotinic acid in rat tissues] [J]. Ukr Biokhim Zh.1996,68 (2):29-33.
[18]Yoshimatsu H, Tsuda K, Niijima A, et al. Histidine induces lipolysis through sympathetic nerve in white adipose tissue [J]. Eur J Clin Invest.2002,32 (4):236-41.
[19]Martineau L, Jacobs I. Effects of muscle glycogen and plasma FFA availability on human metabolic responses in cold water [J]. J Appl Physiol.1991,71 (4):1331-9.
[1]Waters NJ, Waterfield CJ, Farrant RD, et al.Metabo-nomic deconvolution of embedded toxicity:applicationto thioacetamide hepato-and nephrotoxicity[J]. Chem ResToxicol.2005; 18(4): 639-654.
[2]Lindon J C, Holmes E, Nicholson J K. Recent Developments and Applications of NMR-Based Metabonomics [J]. 波普学杂志,2006,11 (2):23
[3]Assy N, Kaita K, Mymin D, et al. Fatty infiltration of liver in hyperlipidemic patients [J]. DigDisSci,2000,45 (10):1929-1934.
[4]Marchesini G, Brizi M, Bianchi G, et al. Nonacoholic fatter liver disease:a featureof the metabolic syndrom[J]e. Diabetes,2001,50 (8):1844-1850.
[5]Bello-Ramirez AM, Nava-Ocampo AA. A QSAR analysis of toxicity of Aconitumalkaloids[J].Fundam Clin Pharmacol,2004,18 (6):699-704.
[6]Raamsdonk L M, Teusink B, Broahurst D, et al. A functional genomics strategy that uses melaholome data to reveal the phenptype of silent mutations [J]. Nat Biotedi,2001,19 (3):45-50.
[7]吕志平,刘承才.“肝郁”大鼠的脂质过氧化反应及逍遥散的保护作用[J].山东中医学院学报,1995(3)：199-201
[8]Balkan J,Kanbaglii O, Aykag-toki jr G., et al.Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[9]Nandhini A T, Balakrishnan S D, Anuradha C V. Response of liver antioxidant system to taurine in rats fed high fructose diets [J]. Indian J Exp Biol,2002,40(9):1016-1024.
[10]Wu C, Kennedy D 0, Yano Y, et al.Thiols and polyamines in the cytoprotective effect of taurine on carbon tetrachloride induced hepato-toxicity[J]. J Biochem Mol Toxicol,1999,13(2):71-76.
[11]Nicholls AW,Mortishire-Smith RJ, Nicholson JK, et al.NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats [J]. Chem Res Toxicol,2003, 16(11):1395-1404.
[12]MinjunChen, Liping Zhao, Weijia, et al. Metabonomic study on the biochemical profile of hydrocortisone induced anilmal model [J]. Joumal of Proteme Research,2005,4 (6):2391-2396
[13]李中峰，昊惠丰,张晓宇,等.轻稀土镧、铈急性生物效应的血清1H-NMR谱代谢组学研究[J].高等学校化学学报,2006,27：438-442.
[14]Holmes E,Nicholls AW, Lindon JC,et al.Development of a model for classification of toxin-induced lesions using 1H NMR spectr oscopy of urine combined with pattern recognition[J]. NMR Biomed. 1998,11:235-246.
[15]Minju Chen, Liping Zhao, Jianjiang, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats [J]. Jourmal of proteme Research,2006,5 (4):95-100
[16]Hensley K, Kotake Y, Sang H, et al. Dietary choline restriction causes Compels Idysfunction and increased H2O2 generation in liver mitochondr[J]a. Carcinogenesis,2000,21:983-989.
[1]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi-systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[2]LU Yi-hong, HAO Hai-ping, WANG Guang-ji, ea tl. Chinese Pharmacological Society [J]. Chinese Pharmacological Society,2007, 12(10):1144-1150
[3]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo—nomics: metabolic processes studied by NMR spectroscopy of biofluids [J]. Concepts Magn Resort,2000,12(5):289-320.
[4]Nicholson JK, Foxall PJ, Spraul M, Farrant RD, LindonJC.750 H NMR spectroscopy of humanblood plasma [J]. Aria/Chem,1995,67 (5): 793-811.
[5]Constantinou M A, Papakonstantinon E, Sprawl M, et al. 1H-NMR based metabonomics for the diagnosis of inborn errors of metabolism in urine[J]. Analytica Cbimica Acta,2005,542 (2): 169-177.
[6]罗和古丁杰.大鼠肝郁脾虚的代谢组学研究[J].中西医结合学报,2007，5，(3)：307
[7]徐舒,陈合兵,李洪等.“肝郁证”大鼠模型的建立及代谢组学的初步研究[J].中华中医药杂志,2009,6(34)：6
[8]. ChuangCK, LinSP, ChenHH, etal. Plasmafree aminoacids and their metabolitesin Taiwanese Patienison hemodialy sisandeontinuou sambulatory Peritonealdialysis [J].Clin Chim Aeta.2006, 364(12):209-216
[9]Tang H R, Wang Y L. Metabonomics:arevo lutionin progress [J]. Prog Biochem Biophys,2006,33(5):401-417
[1]Nicholson JK, Lindon JC, Holmes E.'Metabonomics':understanding the metabolic responses of livi systems topathophysiologieal stimuli multivariate statistical analysisof biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[2]Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabo—nomics: metabolic processes studied by NMR spectroscopy of biofluids[J]. Concepts Magn Resort,2000,12(5):289-320.
[3]Nicholson JK, Foxall PJ, Spraul M, Farrant RD, LindonJC.750 H and H-OC NMR spectroscopy of humanblood plasma [J]. Aria/Chem, 1995,67(5):793-811.
[4]El-Deredy W. Pattern recognition approaches in biomedicaland clinical magnetic II solmnce spectros copy:a review[J]. NMR B/ omed,1997,10(3):99-124.
[1]陈锦锋,王爱成,王玉来,等.肝气郁结证诊断的必备症状以及与抑郁状态的关系探讨[J].辽宁中医杂志,2005,32(1)：19-23
[2]骆抗先,毛乾国.慢性乙型肝炎的治疗[J].临床肝胆病杂志,2004,20 (4)：70.
[3]Emmet B. keeffe, Douglas T. dieterich, Steve-huy B. han,et al. A t reatment algorit hm for t he management of chronic hepatitis B virhs infection in t he united states [J]. Clinic Gast roenterology and Hepa tology,2004,2 (2):87.
[4]全国病毒性肝炎学术组.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1)：56-62
[5]盛国平.基于GC-MS和LC-MS技术的肝病代谢组学研究[C].浙江大学博士论文,2008年4月
[6]Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states [J]. Psychosom Med.2003,65 (4):665-71.
[7]陈泽奇陈国林金益强等. 肝气郁结证病理生理学基础研究[J].中国现代医学杂志,2000,10(10)：21
[8]HeilSA, Wiehems C, MossnerR, etal. Functional Eharaeterization of them urineser otonintrans Portergene Promoterin Sero-tonergiera Pheneurons[J]. J Neuroehem,1998,70(3):932-939
[9]Ellis PM, Salmond C. Imipramineb indingin depression:A Meta-analysis[J]. BiolPsychiatry,1994,36(5):292-299
[10]Holmes E, Tang H R, Wang Y L, et al. The assessment of plant metabolite profiles by NMR-based methodologies [J]. Plant Med, 2006,72(9):771-785
[1].PostieC, DentinR, GirardJ.Role of the liver in the eonirol of earbohy drate and liPidho meostasis [J]. Diabete sMetab.2004, 30(5):398-408.
[2]Raamsdonk L M, Teusink B, Broahurst D, et al. A functional genomics strategythat uses melaholome data to reveal the phenptype of silent mutations[J]. Nat Biotedi,2001,19 (3):45-50
[3]Bello-Ramirez AM, Nava-Ocampo AA. A QSAR analysis of toxicity of Aconitumalkaloids[J].Fundam Clin Pharmacol,2004,18 (6):699-704..
[4]王晓艳,应激及其药物干预的代谢组学研究[A].上海交通大学博士论文,2007年7月
[5]Teresa W.-M. Fan, Andrew N. Lane. Structure-based profiling of metabolites andisotopomers by NMR [J]. Progress in Nuclear Magnetic Resonance Spectroscopy,2007,2:1-49.
[6]Fedyk M, Velykyi MM, Zababurina ML, et al. [The dynamic biosynthesis of nicotinamide coenzymes from nicotinamide and nicotinic acid in rat tissues [J].Ukr Biokhim Zh.1996,68 (2): 29-33.
[7]Martineau L, Jacobs I.Effects of muscle glycogen and plasma FFA availability on human metabolic responses in cold water [J]. J Appl Physiol.1991,71 (4):1331-9.
[8]Yoshimatsu H, Tsuda K, Niijima A, et al. Histidine induces lipolysis through sympathetic nerve in white adipose tissue [J]. Eur J Clin Invest.2002,32 (4):236-41.
[9]Balkan J, Kanbaglii O, Aykag-toki jr G., et al.Taurine treatment reduces hepaticlipids and oxidative stress in chronically ethanol-treated rats[J].Biol Pharm Bull,2002,25 (9):1231-1233.
[10]Nandhini A T, Balakrishnan S D, Anuradha C V. Response of liver antioxidantsystem to taurine in rats fed high fructose diets [J]. Indian J Exp Biol,2002,40(9):1016-1024.
[11]Wu C, Kennedy D O, Yano Y, et al.Thiols and polyamines in the cytoprotectiveeffect of taurine on carbon tetrachloride induced hepato-toxicity[J].J Biochem Mol Toxicol,1999,13 (2):71-76.
[12]李中峰,昊惠丰,张晓宇,等.轻稀土镧、铈急性生物效应的血清1H-NMR谱代谢组学研究[J].高等学校化学学报,2006，27：438-442.
[13]Holmes E,Nicholls AW, Lindon JC,et al.Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition[J]. NMR Biomed.1998,11:235-246.
[14]罗和古丁杰徐舒,陈合兵,李洪等.大鼠肝郁脾虚的代谢组学研究[J].中西医结合学报,2007,5(3)：307
[15]. ChuangCK, LinSP, ChenHH, etal. Plasma free aminoacids and their Metabolites in Taiwan ese Patienison hemodialysis and eontinuous ambulatory Peritonealdialysis [J].Clin Chim Aeta.2006, 364(12):209-216
[16]徐舒陈合兵李洪等.“肝郁证”大鼠模型的建立及代谢组学的初步研究[J].中华中医药杂志,2009, (6)：787-791
[17]Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states [J]. Psychosom Med.2003,65 (4):665-71.
[18]owens MJ, Nemeroff CB. Theroleofserotonin in the PathoPhysi ology of depression:Foeus ontheser otonintrans Porter [J].Clin Chem,1994,40(2):288-295
[19]陈泽奇陈国林金益强等.肝气郁结证病理生理学基础研究[J].中国现代医学杂志,2000,10(10)：12
[1]Nicholson J K,Lindon J C,Holmes E.'Metabonomics':understanding the metabolic responses of living systems to pathoph-ysiologieal stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica,1999 29(11):1181-1189
[2]Fiehn. Metabolomics-the link between genotypes and phenotypes [J]. Plant Mol Biol,2002,48(1-2):155-171
[3]张杰,李涢.关于中医证候物质基础研究路径的思考[J].中国中医基础医学杂志,2007,13(5)：394
[4]李翰旻,毛树松.中医证候信息学[J]中华中医药学刊2008,7,(26)：1374-1378
[5]蒋功成.系统生物医学与中医现代化[J].医学与哲学,2006；27(12)：13-29
[6]Bollard M E, Stanley E G, Lindon J C, et al. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition [J]. NMR in Biomedicine, 2005,18:143-162
[7]B. Teusink, F. Baganz, H. V. Westerhoff, et al. Metabolic control analysis as a tool in the elucidation of the function of novel genes [J]. Methods in Microbiology,1998,26:297-336
[8]German J B, Bauman D E, Burr in D G, et al. Metabolomics in the opening decade of the 21st century:building the roads to individualized health [J]. Nutrue,2004,134(10):2729
[9]Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1 H-NMR-based metabonomics [J]. Nature Medicine, 2002,8(12):1439-1444
[10]Jun Yang, Guowang Xu, Yufang Zheng. Strategy formetabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry [J]. Journal of chromatographya,2005,1084:214-221.
[11]Nicholson J K, Wilson I D. Understanding "global" systems biology:Mctabonomics and the continuum of metabolism[J]. Nat Rev Drug Discov,2003,2(8):668-676
[12]Hood L, Heath J R, Phelps M E, et al. Systemsbiology and new technologies enable predictive and preventative medicine [J]. Science,2004,306(5296):640-643
[13]Nicholson J K. Global systems biology, personalized medicine and molecular epidemiology [J]. Mol Systems Biol,2006,2:52
[14]陈竺.系统生物学--21世纪医学和生物学发展的核心驱动力[J].世界科学,2005,(3)：4-5
[15]Lindon J C, Holmes E, Nicholson J K. Recent Developments and Applications of NMR-Based Metabonomics [J].波普学杂志,2006, 11(2):23
[16]MinjunChen, Liping Zhao, Weijia, et al. Metabonomic study on the biochemical profile of hydrocortisone induced anilmal model [J]. Joumal of Proteme Research,2005,4(6):2391-2396
[17]Minju Chen, Liping Zhao, Jianjiang, et al. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats [J]. Jourmal of proteme Research,2006,5(4):95-100
[18]王米渠,冯韧,严石林,等.基因表达谱芯片与中医寒证的7类相关基因[J].中医杂志,2003,44(4)：288
[19]杨丽萍,陆明,王米渠,等.免疫代谢类基因差异表达评价肾阳虚骨关节炎个案疗效[J].河南中医,2004,17(9)：1
[20]王米渠.肾虚证的基因组与信息融合的研究前瞻-中医科研前言进取功能基因组[J].亚太生技,2004,2(1)：43
[21]李林,王建农,任建勋,等.气虚血瘀证大鼠尿液的核磁共振谱代谢组学[J].科学通报,2007,52(15)：1758
[22]罗和古,丁杰,岳广欣,等.大鼠肝郁脾虚证的代谢组学研究[J].中西医结合学报,2007,5(3)：307
[23]郑丽红.脾气虚证唾液代谢组学的初步研究[A].广州中医药大学硕士学位论文,2007,5
[24]童宁宁.慢性胃炎湿热蕴脾证唾液代谢组学的初步研究[A].广州中医药大学,硕士学位论文,2006；4
[25]LU Yi-hong, HAO Hai-ping, WANG Guang-ji, ea tl. Chinese Pharmacological Society[J]. Chinese Pharmacological Society, 2007,12(10):1144-1150
[26]Arthur JM, Thongboonkerd V, Scherzer JA, et al. Differential ex2 pression of proteins in renal cortex and medulla:a proteomic ap2 proach[J]. Kidny Int,2002,62(8):1314-1318
[27]Tang H R, Wang Y L. Metabonomics:arevolutioninprogress [J]. Prog Biochem Biophys,2006,33(5):401-417
[28]Holmes E, Tang H R, Wang Y L, et al. The assessment of plant metabolite profiles by NMR-based methodologies [J]. Plant Med,2006,72(9):771-785
[1]陆明霞,陈乃明.针刺疏肝理气法研究[J].山东中医药大学学报,1999,23(1)：30.
[2].谢小冰,张问渠.高血压病肝郁证5-羟色胺变化的探讨[J].云南中医杂志,1987,8(4)：4-5
[3].乔明琦,张珍玉.肝气逆、肝气郁两证客观指标实验研究[J].山东中医学院学报,1992,16：23-26
[4].王霞灵,周大桥.肝郁患者血清泌乳素测定临床意义探讨[J].湖北中医杂志,1995,17(5)：53-54
[5].王希浩,刘明,张萍,等.肝郁型月经病与血清泌乳素水平关系的研究[J].中医研究,1992,5(2)：26-28
[6].文哲双,王志忠,朱毅.肝郁患者血清T、E2、PRL水平检测及其临床意义[J].湖中医学院学报,2000,2(2)：27-29
[7].王霞灵,周大桥,李延福.肝郁患者雌激素水平研究[J].湖北中医杂志,1996,18(4)：38-39
[8].王希浩,贾可夫,何玉凡.从内分泌学探讨肝郁证月经病病理机制[J].实用中西医结合杂志,1995,8(12)：757-758、
[9].黄晖,傅贞亮,董笃一,等.中医肝病124例血清甲状腺激素的观察[J].中医杂志,1992,33(10)：40-42
[10]严灿,张新春,邓中炎.肝主疏泄免疫学机制的临床与实验研究[J].中国中医基础医学杂志,1995,1(3)：37
[11]严灿,邓中炎,王剑.调肝方药对慢性束缚应激大鼠神经内分泌免疫功能的影响[J].中国免疫学杂志,2000,(16)：488-490
[12]严灿,高敏,张新春,等.肝郁证免疫机能改变机制的临床与实验研究[J].中医研究,1995,8(6)：18-20.
[13]陈松,李家邦,朱双罗,等.肝郁证T、B淋巴细胞活性改变及疏肝治疗影响的实验研究[J].湖南中医学院学报,2001,21(2)：7-8
[14]许辉,陈松,李家邦,等.特异性免疫应答在肝郁证与脾虚证及相互关系的初步研究[J].中国医师杂志,2002,4(8)：829-834
[15]陈泽奇,陈国林,石林阶,等,肝气郁结证患者血浆L-NEK、AvP、ANP含量分析[J],湖南中医学院学报,1997,17(3)：37-39
[16]陈泽奇,陈国林,李学文,等,肝气郁结证患者血浆抗利尿激素的变化[J].华人消化杂志,1998,6(6)：495-496
[17]文哲双,王志忠,朱毅.肝郁患者血清T、E2、PRL检测及其临床意义[J].湖北中医药大学学报,2000,2(2)：27-29
[18]常德贵,王峥屹,祝彼得,等.疏肝理气活血法对肝郁气滞大鼠阴茎海绵体PDE5活性影响的实验研究[J].中华男科学,2004,10(1)：71-73
[19]1张向渠,等.高血压病肝郁证的临床研究[J].中西医结合杂志,1987,7(7)：396
[20]陈建伟,李祥,陈进,等.正常人与肝气郁结证人指甲中无机元素的比较分析[J].广东微量元素科学,2001,8(11)：34-37
[21]俞亚琴,郭合钧,肠道易激征患者的中医辨证与微量元素关系的实验研究[J].中医药研究,1997,13(4)：46
[22]黎杏群,等.肝阳上亢证患者血浆血栓素B2和6-酮-前列腺素F1[J].湖南医学院学报,1989,14(1)：43-45
[23]杨冬花,李家邦,郑爱华,等.肝气郁结证模型大鼠Th1：/Th2细胞因子变化及柴胡疏肝散的干预作用[J].湖南中医学院学报,2003,23(5)：4-7
[24]郑爱华,李家邦,蔡光先,等.柴胡疏肝散、四君子汤对肝郁、脾虚病人Th细胞分化信号蛋白PKC表达的影响[J].贵阳中医学院学报,2003,25(4)：14-17
[25]崔向阳,等。.60例肝郁气滞及相关证候病人的血液流变性变化的初步研究[J].黑龙江中医药,1989,(5)：49
[26]金益强,中医肝脏象现代研究与临床[M].第1版,人民卫生出版社,2000：16-18
[27]李爱中,等.60例肝郁气滞及其相关证候病人的甲襞微循环变化浅析[J].黑龙江中医药,1989,(5)：50-51
[28]陈泽奇,等.肝风内动证患者球结膜微循环状态研究[J].现代医学杂志,1992,2(1)：12-14
[29]朱双罗,等.中医肝病不同证型患者个性特征的研究[J].当代医师杂志,1997,2(3)：15-17
[30]黄炳山,等.肝郁气滞证A型性格黑[J].龙江中医药,1989,(5)：24
[31]施和勋,肝气郁结患者症状自评量表(SCL-90)评定结果分析[J].浙江中西医结合杂志,1999,9(2)：85-86
[32]吴涛,胡随瑜,肝气郁结证患者情绪状态的评估与血浆神经降压素水平的Q初步研究[J].湖南中医学院院报,2001,21(3)：5-13
[33]陈泽奇,胡随瑜,刘盛,肝气郁结证患者焦虑\抑郁测量结果分析[J].湖南中医学院学报,2000,20(1)：4-5
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |